Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Sawai and T’s Pharma Won Forxiga Generics by Skirting Patent, Will the Strategy Hold?
September 11, 2025
-
REGULATORY Reblozyl Faces Price Cut after Cost-Effectiveness Assessment
September 11, 2025
-
BUSINESS Teijin Pharma Bets on Ascendis Rare Disease Assets as Feburic Sales Crumble
September 10, 2025
-
BUSINESS Amicus CEO Confident on US$1 Billion Sales Target as Japan Pompe Launch Gets Underway
September 9, 2025
-
BUSINESS KM Biologics Developing Higher-Yield Liquid Immunoglobulin to Boost Efficiency and Supply
September 8, 2025
-
ORGANIZATION JPMA Code & Compliance Chair Stresses Need to Embed Spirit of Revised COP
September 8, 2025
-
COMMENTARY MHLW Grows Jittery over Supply Risks amid Rising Foreign Investments
September 8, 2025
-
BUSINESS And Pharma Chief Pledges Growth Strategy as New Generics Holding Firm Takes Shape
September 5, 2025
-
ORGANIZATION JPMA ICH Project Chair Sees RWE as Potential Complement to Clinical Trials
September 5, 2025
-
BUSINESS Bayer Pushes Cross-Border Open Innovation with New Co.Lab Connect Program
September 4, 2025
-
ORGANIZATION JPMA Regulatory Chief Seeks Balanced Approach on Japanese PI Waivers
September 3, 2025
-
REGULATORY Pharma Groups Press Pricing Reform at First Public-Private WG Meeting
September 2, 2025
-
REGULATORY Japan Panel Clears Izervay, Nexletol for Approval; Eylea Biosimilars Edge Ahead Too
September 1, 2025
-
REGULATORY METI Proposes “Bold Investment” Tax Breaks in FY2026 Request
September 1, 2025
-
REGULATORY Japan Panel Green Lights Nonprescription Switch of Morning-After Pill
September 1, 2025
-
REGULATORY MHLW Orders Label Revision for Elevidys to Add Acute Hepatic Failure
September 1, 2025
-
ORGANIZATION Indicators Needed to Frame Pharma as Growth Market in Japan, Says JPMA Policy Chief
August 29, 2025
-
REGULATORY Japan to Expand List of “Stable Supply Medicines” to 759 APIs, Adding Vaccines and Blood Products
August 28, 2025
-
COMMENTARY Pharmacies Reel from Pricey Drug Waste, Sparking Calls for Packaging Overhaul and Price Penalties
August 27, 2025
-
REGULATORY MHLW Pharma Bureau Seeks FY2026 Budget to Bolster PMDA and Speed Up SaMD Reviews
August 27, 2025
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…